
09.11.2023
Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York
04.05.2023
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!
Genekam has developed human antibodies (true antibodies, therapeutic antibodies) against H5N1 and now we are working to generate sufficient quantity to conduct other assays!